C
Carlos Manrique
Researcher at Montefiore Medical Center
Publications - 12
Citations - 326
Carlos Manrique is an academic researcher from Montefiore Medical Center. The author has contributed to research in topics: Cancer & Heart failure. The author has an hindex of 5, co-authored 12 publications receiving 277 citations. Previous affiliations of Carlos Manrique include Albert Einstein College of Medicine & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials.
Omar Wever-Pinzon,Jorge Romero,Iosif Kelesidis,James Wever-Pinzon,Carlos Manrique,Deborah Budge,Stavros G. Drakos,Ileana L. Piña,Abdallah G. Kfoury,Mario J. Garcia,Josef Stehlik +10 more
TL;DR: CCTA using currently available technology is a reliable noninvasive imaging alternative to coronary angiography with an excellent sensitivity, specificity, and NPV for the detection of CAV.
Journal ArticleDOI
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review
TL;DR: Diagnosis is often difficult due to the nonspecific nature of the disease and the broad spectrum of phenotypic variations, therefore consensus diagnostic criteria have been developed and combined electrocardiography, echocardiography, cardiac magnetic resonance imaging (CMRI) and myocardial biopsy.
Journal ArticleDOI
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
Anthony F. Yu,Carlos Manrique,Shawn C. Pun,Jennifer E. Liu,Elton Mara,Martin Fleisher,Sujata Patil,Lee W. Jones,Richard M. Steingart,Clifford A. Hudis,Chau T. Dang +10 more
TL;DR: The results of a preplanned cardiac safety analysis of global longitudinal strain (GLS), and troponin-I (TnI) and brain natriuretic peptide (BNP) levels in the phase II study of paclitaxel, trastuzumAB, and pertuzumab for metastatic HER2-positive breast cancer are reported.
Journal ArticleDOI
Cancer Survivorship: Cardiotoxic Therapy in the Adult Cancer Patient; Cardiac Outcomes With Recommendations for Patient Management
TL;DR: The therapies that have led to advances in cancer survival and the acute and chronic cardiovascular toxicities associated with these therapies are described and a series of recommendations for surveillance and management of cardiovascular disease in cancer survivors are made.
Journal ArticleDOI
Diagnostic Strategies for Early Recognition of Cancer Therapeutics–Related Cardiac Dysfunction
TL;DR: The current evidence and recommendations for biochemical and noninvasive diagnostic techniques, including their specific role for identification of CTRCD, are examined, providing an updated document for the health professionals involved in the care of patients with cancer.